| 000 | 03315nam a2200217Ia 4500 | ||
|---|---|---|---|
| 999 |
_c34106 _d34106 |
||
| 003 | OSt | ||
| 005 | 20210624130756.0 | ||
| 008 | 160316s2009 xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9781847209801 | ||
| 040 | _cn | ||
| 082 |
_a346.048000 _bCAS |
||
| 100 | _aCastle David | ||
| 245 | _aThe role of intellectual property rights in biotechnology innovation | ||
| 260 |
_aLondon _bEdwrad Elgar _c2009 |
||
| 300 |
_a459p _cxiv |
||
| 365 | _b Rs. 3,080 | ||
| 505 | _aTable of contents Introduction David Castle; PART I: INTELLECTUAL PROPERTY RIGHTS IN INNOVATION SYSTEMS; 1. Introduction David Castle; 1. Are Intellectual Property Rights Quanta of Innovation? J. Adam Holbrook; 2. Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global Context Bjorn Asheim, Finn Valentin and Christian Zeller; 3. Intellectual Property Rights Policy for Gene-Related Inventions - Toward Optimum Balance Between Public and Private Ownership Koichi Sumikura; PART II: INTELLECTUAL PROPERTY MANAGEMENT IN BIOTECHNOLOGY ; Introduction Karen L. Durell; 4. Fundamentals of Intellectual Property Management Patrick H. Sullivan; 5. Making a Return on R&D: A Business Perspective Sharon Oriel; 6. Looking Beyond the Firm: Intellectual Asset Management and Biotechnology Karen L. Durell and E. Richard Gold; PART III: INTELLECTUAL PROPERTY RIGHTS IN RELATION TO OTHER MEASURES OF INNOVATION; Introduction L. Martin Cloutier and David Castle; 7. Increasing Internal Value from Patents: The Role of Organizational Arrangements Marc Ingham, Cecile Ayerbe, Emmanuel Metais and Liliana Mitkova; 8. Language System (LS) 3.0: An Agenda for a Model of Innovation Valuation Clinton W. Francis; 9. Measurement of Innovation and Intellectual Property Management: Challenging Processes L. Martin Cloutier and Susanne Sirois; PART IV: BEYOND PATENT LENGTH; Introduction Amy J. Glass and Fabricio X. Nunez; 10. Open Development: Is the 'Open Source' Analogy Relevant to Biotechnology? Alan G. Isaac and Walter G. Park; 11. On the Border: Biotechnology, the Scope of Intellectual Property and the Dissemination of Scientific Benefits Christopher May; 12. On the Comparative Institutional Economics of Intellectual Property in Biotechnology F. Scott Kieff; PART V: INNOVATION GOVERNANCE; Introduction Tania Bubela; 13. Accessibility of Biological Data: A Role for the European Database Right? Jasper A. Bovenberg; 14. Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance? Timothy Caulfield; 15. Agricultural Biotechnology and Trends in the Intellectual Property Rights Regime: Emerging Challenges for Developing Countries Sachin Chaturvedi; PART VI: NATIONAL, INTERNATIONAL AND HISTORICAL COMPARISONS; Introduction Abdallah S. Daar and David Castle; 16. The Role of Intellectual Property Rights in Biotechnology Innovation: National and International comparisons Richard Y. Boadi; 17. Intellectual Property, Information and Divergences in Economic Development - Institutional Patterns and Outcomes circa 1421-2000 Ian Inkster; 18. Watch What You Export: The History of Medical Exceptions from Patentability Tina Piper; Index | ||
| 650 | _a1. Biotechnology - Congresses2. Biotechnology - Law & Legislation3. Intellectual Property | ||
| 700 |
_a _a |
||
| 942 |
_2ddc _cBK |
||